Similar articles

• Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.

  Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR. Rothberg MB, et al. Ann Intern Med. 2005 Aug 16;143(4):241-50. doi: 10.7326/0003-4819-143-4-200508160-00005. Ann Intern Med. 2005. PMID: 16103468
• Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.

  Rubboli A, Halperin JL. Rubboli A, et al. Thromb Haemost. 2008 Nov;100(5):752-3. Thromb Haemost. 2008. PMID: 18989515 No abstract available.
• Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.

  Roldán V, Marín F. Roldán V, et al. Thromb Haemost. 2008 Nov;100(5):754-5. Thromb Haemost. 2008. PMID: 18989516 No abstract available.
• Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

  Arjomand H, Cohen M, Ezekowitz MD. Arjomand H, et al. J Invasive Cardiol. 2004 May;16(5):271-8. J Invasive Cardiol. 2004. PMID: 15152137 Review.
• Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?

  Lip GY, Varma C. Lip GY, et al. Thromb Res. 2006;118(4):429-32. doi: 10.1016/j.thromres.2005.09.012. Epub 2005 Nov 7. Thromb Res. 2006. PMID: 16274734 Review. No abstract available.